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Biomarkers to improve rational antibiotic use in low-resource 
settings
The high and continuous rise of antibiotic use in low-
income primary-care settings have called for the use 
of point-of-care biomarker testing, such as testing 
of C-reactive protein (CRP), to enhance antimicrobial 
stewardship interventions. Detecting the minority of 
patients with serious bacterial infections is challenging 
for health workers, particularly because of the scarcity 
of adequate diagnostics. To date, the optimal strategy 
of using biomarkers to inform antibiotic prescription in 
such settings is unclear.
In this issue of The Lancet Global Health, Thomas 
Althaus and colleagues1 report the results of an 
individually randomised controlled trial that 
assessed the effect of two different CRP thresholds 
(20 mg/L and 40 mg/L) on the proportion of antibiotic 
prescriptions, when compared with current practice, 
among 2410 febrile patients in primary care in 
Thailand and Myanmar. The study included both 
children older than 1 year and adults, and showed that 
CRP point-of-care testing at a threshold of 40 mg/L 
might reduce antibiotic prescribing compared with 
current practice in these settings, albeit with only a 
modest absolute risk reduction of 5% (intervention 
group 34% and control group 39%). No differences 
in clinical recovery and severe adverse events were 
observed, although the study was not powered for 
these clinical outcomes. Althaus and colleagues1 
are to be commended for completing such a large 
multicentre, multicountry trial with diversity in terms 
of rural and urban environments. Importantly, and 
contrary to previous studies that assessed CRP use in 
southeast Asia,2 this trial included patients at risk of 
bacterial infections—ie, patients who would benefit 
from biomarker testing.
The trial conveys several key messages related 
to the integration of biomarkers into primary-care 
antibiotic-stewardship interventions in low-resource 
settings. First, the study underlines that biomarker 
validation studies should not be limited to analytical 
performance assessments but should rather also 
measure the effects on relevant patient outcomes 
in the context of future implementation.3 Findings 
from diagnostic accuracy studies often do not 
correlate with clinical effect. This discrepancy is in part 
because, especially in paediatrics, adequate reference 
standards to define serious bacterial infections are 
often absent, which makes diagnostic accuracy studies 
challenging.
Furthermore, the absence of effect in the group with 
a low CRP cutoff (20 mg/L) again showed that using 
low-specificity biomarker cutoffs at the primary-care 
level results in antibiotic use in many low-risk patients, 
and does not reduce antibiotic prescription.4 Among 
primary-care patients without clear clinical signs of 
severity, the prevalence of serious bacterial infections 
is low.5 As a result, a higher biomarker threshold with 
adequate specificity should be used to rule-in bacterial 
infection.
In the study by Althaus and colleagues,1 CRP was 
used as a screening test for bacterial infection in all 
patients. However, studies in high-income settings 
have shown that at-risk patient selection through 
the integration of biomarkers into clinical guidelines 
is preferable over screening approaches.6,7 Testing 
only at-risk patients raises the pretest probability of 
disease sufficiently high, so that biomarker testing is 
useful. Restriction of testing to patients at risk based 
on clinical signs might not only result in greater 
effect of the point-of-care biomarker test, but might 
also avoid test wastage. For example, integration of 
biomarker testing into a clinical decision algorithm 
avoided testing of around 60% of febrile children in a 
2017 clinical trial in Tanzania.8 Such electronic decision 
algorithms are possible solutions in supporting 
minimally trained health workers in systematic clin-
ical assessments and in the interpretation of test 
results in a given clinical and epidemiological context. 
Moreover, these algorithms could improve guideline 
adherence;9 indeed, non-compliance appeared to 
be a major contributor to the only modest effect on 
antibiotic prescription in the study by Althaus and 
co-workers.1 86% of CRP measurements were below 
40 mg/L; the potentially attainable reduction in 
antibiotic prescription would have thus been 25%. 
The lower observed effect might also be attributable 
to the trial design itself; because of individual rather 
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than cluster randomisation, providers had to switch 
prescription strategies in between each patient, which 
is challenging. Although individual randomisation 
might be suited for controlled, efficacy studies, it leads 
to contamination in effectiveness studies, especially 
when health-care workers receive little guidance. 
The observed effect is small also because systematic 
patient follow-up in itself might lower antibiotic 
prescription, because providers note that the majority 
of patients in primary care recover spontaneously 
from minor infections.
The results from this study again emphasise that 
effective interventions to reduce antibiotic use cannot 
rely on the introduction of a single diagnostic test.4 
In addition to clinical guidance, provider training, 
patient education, supervision, and policy strategies 
have an important role.11 As Althaus and colleagues1 
note, the results show, despite all the limitations of 
the study, additional gains of CRP testing in reducing 
antibiotic prescription, without effects on clinical 
recovery. These findings support the use of biomarkers 
in targeting antibiotic prescription in low-resource 
settings. Future effectiveness studies should focus on 
assessing biomarker testing within overall antimicrobial 
stewardship interventions, including clinical guidance, 
training, and patient education.
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